The iba1 immunoreactivity was intense in CA1 and CA3 regions of HFD/STZ-treated WT mice but was comparatively dramatically lower in TonEBP+/− mice with DM (Fig. 6a,b). This evidence concerns the gene AIF1 and diabetes mellitus.